Dublin, May 26, 2026 (GLOBE NEWSWIRE) — The “Latin America Pharmaceutical Contract Manufacturing and Research Services Market Size, Share & Trends Analysis Report by Service, Region, and Growth Forecasts, 2026-2033” has been added to ResearchAndMarkets.com’s offering.
The Latin America pharmaceutical contract manufacturing and research services market, valued at USD 20.2 billion in 2025, is expected to reach USD 37.2 billion by 2033, exhibiting a CAGR of 8.1% from 2026 to 2033.
Key growth drivers include cost efficiency, enhanced clinical research capabilities, increased demand for outsourced services, and favorable regulatory frameworks. Additionally, the rising demand for generics and biosimilars, coupled with the need for local pharmaceutical production, is driving the growth of outsourcing services. Global pharmaceutical companies’ investments, improvements in healthcare infrastructure, and government initiatives are boosting domestic manufacturing and innovation. Furthermore, strategic partnerships and technological advancements are enhancing regional competitiveness.
The focus on cost efficiency has led pharmaceutical companies to collaborate with specialized contract manufacturers for biopharmaceutical production. The expansion of the pharmaceutical and biologics sectors, along with an increase in chronic diseases, healthcare expenditure, and demand for affordable medicines, encourages pharmaceutical companies to ramp up production. Outsourcing to contract manufacturers and research organizations enables these companies to meet demand without substantial capital investment.
Product innovation is no longer limited to large biopharma companies; smaller and mid-sized biotech firms in Latin America are pivotal in discovering novel molecules, often leading to partnerships with established players. This trend has compelled contract research organizations (CROs) to secure more partnerships with emerging biotech companies, ensuring ongoing service demand and growth.
Government initiatives in Latin America are enhancing domestic production and healthcare independence, with countries like Brazil and Mexico providing public funding, tax incentives, and technology transfer programs to support local biologics manufacturing. Brazil’s government-backed partnerships in public healthcare policy have significantly increased local biologics production, reducing dependence on imports. Regulatory bodies like ANVISA have simplified approval processes, allowing for easier scaling of manufacturing operations. Such policy-driven initiatives are bolstering regional capabilities, attracting investment, and driving growth in the pharmaceutical manufacturing sector
Furthermore, companies are expanding their global influence by upgrading and expanding domestic specialty manufacturing facilities while pursuing international collaborations. The presence of major market players such as Thermo Fisher Scientific and IQVIA in countries including Brazil, Mexico, Argentina, and Chile accelerates market growth. Supportive regulatory improvements, increased clinical trial activity, and a growing skilled workforce enhance the region’s attractiveness as a hub for pharmaceutical development and outsourcing services.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover trends and drivers shaping the market’s future.
- Actionable Recommendations: Use insights to uncover new revenue streams and guide strategic business decisions.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 120 |
| Forecast Period | 2025 – 2033 |
| Estimated Market Value (USD) in 2025 | $20.2 Billion |
| Forecasted Market Value (USD) by 2033 | $37.2 Billion |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Latin America |
Companies Featured
- Boehringer Ingelheim International GmbH
- Fresenius Kabi AG
- Unither Pharmaceuticals
- Lonza
- Pfizer Inc.
- Charles River Laboratories
- Laboratory Corporation of America Holdings
- IQVIA, Inc.
- Recipharm AB.
- AbbVie, Inc.
- Catalent, Inc.
- West Pharmaceutical Services, Inc.
Latin America Pharmaceutical Contract Manufacturing & Research Services Market Report Segmentation
Service Outlook (Revenue, USD Million, 2021-2033)
- Manufacturing
- API/Bulk Drugs
- Advanced Drug Delivery Formulations
- Packaging
- Finished Dose Formulations
- Solid
- Liquid
- Semi-solid Formulations
- Research
- Oncology
- Vaccines
- Inflammation & Immunology
- Cardiology
- Neuroscience
- Others
Regional Outlook (Revenue, USD Million, 2021-2033)
- Latin America
- Brazil
- Colombia
- Argentina
- Chile
- Venezuela
- Peru
- Uruguay
- Ecuador
- Bolivia
For more information about this report visit https://www.researchandmarkets.com/r/anceev
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Latin American Pharmaceutical Contract Manufacturing and Research Services Market
